Optimizing clozapine treatment

J Nielsen; P Damkier; H Lublin; D Taylor

doi:10.1111/j.1600-0447.2011.01710.x

Optimizing clozapine treatment

J Nielsen, P Damkier, H Lublin, D Taylor

Psykiatrisk Center Glostrup

112 Citationer (Scopus)

Abstrakt

Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug. This clinical overview aims to provide psychiatrists with knowledge about how to optimize clozapine treatment. Relevant strategies for reducing side-effects and increasing the likelihood of response are discussed.

Originalsprog	Engelsk
Tidsskrift	Acta Psychiatrica Scandinavica
Vol/bind	123
Udgave nummer	6
Sider (fra-til)	411-22
Antal sider	12
ISSN	0001-690X
DOI	https://doi.org/10.1111/j.1600-0447.2011.01710.x
Status	Udgivet - 1 jun. 2011

Adgang til dokumentet

10.1111/j.1600-0447.2011.01710.x

Citationsformater

@article{4c5cdb0649074fb8aa7cf369cb6e7180,

title = "Optimizing clozapine treatment",

abstract = "Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug. This clinical overview aims to provide psychiatrists with knowledge about how to optimize clozapine treatment. Relevant strategies for reducing side-effects and increasing the likelihood of response are discussed.",

author = "J Nielsen and P Damkier and H Lublin and D Taylor",

note = "{\textcopyright} 2011 John Wiley & Sons A/S.",

year = "2011",

month = jun,

day = "1",

doi = "10.1111/j.1600-0447.2011.01710.x",

language = "English",

volume = "123",

pages = "411--22",

journal = "Acta Psychiatrica Scandinavica",

issn = "0001-690X",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "6",

}

TY - JOUR

T1 - Optimizing clozapine treatment

AU - Nielsen, J

AU - Damkier, P

AU - Lublin, H

AU - Taylor, D

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug. This clinical overview aims to provide psychiatrists with knowledge about how to optimize clozapine treatment. Relevant strategies for reducing side-effects and increasing the likelihood of response are discussed.

AB - Clozapine treatment remains the gold standard for treatment-resistant schizophrenia, but treatment with clozapine is associated with several side-effects that complicate the use of the drug. This clinical overview aims to provide psychiatrists with knowledge about how to optimize clozapine treatment. Relevant strategies for reducing side-effects and increasing the likelihood of response are discussed.

U2 - 10.1111/j.1600-0447.2011.01710.x

DO - 10.1111/j.1600-0447.2011.01710.x

M3 - Journal article

C2 - 21534935

VL - 123

SP - 411

EP - 422

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

SN - 0001-690X

IS - 6

ER -

Optimizing clozapine treatment

Abstrakt

Adgang til dokumentet

Fingeraftryk

Citationsformater